Articles
Immunotherapy’s Hidden Burden: Rethinking Toxicity in the Era of Breakthroughs
Immunotherapy has redefined cancer care—offering survival where little once existed, and in some cases, the possibility of long-term remission. But as its use expands across tumor types and earlier lines of treatment, a more complex reality is coming into focus:…
After the Bell: Rethinking Cancer Care Beyond Treatment
As cancer survival improves, a critical gap persists: the period after treatment, where psychological distress, identity disruption, and unmet needs remain insufficiently addressed in routine oncology care. A System Designed for Treatment, Not Transition “We have to be next to…
From Silence to Presence: Dr Christian Ntizimira on Reimagining End-of-Life Care
Dr Christian Ntizimira, MD, MMsGHE, Founder and Executive Director of the African Center for Research on End-of-Life Care (ACREOL), and author of “The Safari Concept: An African Framework on End-of-Life Care,” speaks about dignity, suffering, and reimagining care at the…
A Survivor’s Perspective: San Diego’s Rise as a National Cancer Research Hub
How policy, philanthropy, and scientific collaboration are reshaping the cancer research landscape and why early detection can be the difference between life and death. Twenty years ago, I received a diagnosis that changed everything and led me to dedicate the…
Rewriting the Surgical Narrative: Dr Lazaros Papadopoulos On Breast Cancer Care, Mentorship, and the Meaning of Small Changes
“Life is often a sequence of chance events, and many times we are called to rewrite our own narrative.” For Dr Lazaros Papadopoulos, that idea is not abstract. It is the thread that connects a childhood shaped by admiration for…
“Between the Checkpoints of Life, Take the Immunobuddies with You” —Professor Ricky Dylan Frazer
The conversation starts with a small detail that quickly becomes memorable. There is no coffee. On a podcast built around conversations over coffee, Professor Ricky Dylan Frazer, Consultant Medical Oncologist at Velindre Cancer Centre, Deputy CEO of the Immuno-Oncology Clinical…
Charles Balch Treated Thousands of Patients. He Says That’s Not His Greatest Work.
If you try to list everything Charles Balch has done, you quickly realize the list does not help you understand the man. He has led some of the most important institutions in oncology. He has built systems that are now…
Mission 2027: Mission is Possible
The Minister of Health of Rwanda Dr Sabin Nsanzimana on medicine, 1994 genocide against the Tutsi, leadership, workforce, technology, and the ambition to eliminate cervical cancer The latest interview for CancerWorld features Dr Sabin Nsanzimana, Minister of Health of Rwanda, physician, epidemiologist,…
Cancer Vaccines: From Missed Promise to Second Chance
In oncology, some ideas arrive too early. For decades, cancer vaccines were one of them. The concept was elegant: train the immune system to recognise tumour cells, much like it recognises viruses, and allow it to eliminate disease with precision…
Psycho-Oncology at a Crossroads: From Global Recognition to Real-World Impact
The launch of World Psycho-Oncology Day signals growing momentum behind psychosocial care in cancer, but without structural change, millions of patients will continue to go without the support they need. With the announcement of World Psycho-Oncology Day (WPOD), to be…